Nobilis Influenza H5N2

RSS
Authorised

This medicine is authorised for use in the European Union

adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5
MedicineVeterinaryAuthorised
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

български (BG) (93.36 KB - PDF)

View

español (ES) (81.97 KB - PDF)

View

čeština (CS) (93.99 KB - PDF)

View

dansk (DA) (83.34 KB - PDF)

View

Deutsch (DE) (82.76 KB - PDF)

View

eesti keel (ET) (82.18 KB - PDF)

View

ελληνικά (EL) (93.76 KB - PDF)

View

français (FR) (82.44 KB - PDF)

View

hrvatski (HR) (92.27 KB - PDF)

View

íslenska (IS) (83.29 KB - PDF)

View

Gaeilge (GA) (83.57 KB - PDF)

View

italiano (IT) (82.29 KB - PDF)

View

latviešu valoda (LV) (94.29 KB - PDF)

View

lietuvių kalba (LT) (94.03 KB - PDF)

View

magyar (HU) (94.15 KB - PDF)

View

Malti (MT) (95.95 KB - PDF)

View

Nederlands (NL) (82.05 KB - PDF)

View

norsk (NO) (82 KB - PDF)

View

polski (PL) (95.62 KB - PDF)

View

português (PT) (83.01 KB - PDF)

View

română (RO) (94.17 KB - PDF)

View

slovenčina (SK) (94.08 KB - PDF)

View

slovenščina (SL) (82.27 KB - PDF)

View

Suomi (FI) (81.54 KB - PDF)

View

svenska (SV) (82.05 KB - PDF)

View

Product information

български (BG) (91.78 KB - PDF)

View

español (ES) (81.51 KB - PDF)

View

čeština (CS) (92.48 KB - PDF)

View

dansk (DA) (82.05 KB - PDF)

View

Deutsch (DE) (81.72 KB - PDF)

View

eesti keel (ET) (81.22 KB - PDF)

View

ελληνικά (EL) (91.79 KB - PDF)

View

français (FR) (81.63 KB - PDF)

View

hrvatski (HR) (91.56 KB - PDF)

View

íslenska (IS) (81.52 KB - PDF)

View

Gaeilge (GA) (81.36 KB - PDF)

View

italiano (IT) (81.76 KB - PDF)

View

latviešu valoda (LV) (92.14 KB - PDF)

View

lietuvių kalba (LT) (92.19 KB - PDF)

View

magyar (HU) (92.76 KB - PDF)

View

Malti (MT) (93.86 KB - PDF)

View

Nederlands (NL) (81.15 KB - PDF)

View

norsk (NO) (81.52 KB - PDF)

View

polski (PL) (93.22 KB - PDF)

View

português (PT) (82.53 KB - PDF)

View

română (RO) (91.73 KB - PDF)

View

slovenčina (SK) (81.75 KB - PDF)

View

slovenščina (SL) (81.76 KB - PDF)

View

Suomi (FI) (81.11 KB - PDF)

View

svenska (SV) (81.47 KB - PDF)

View
Latest procedure affecting product information: IG/1348
18/03/2021

български (BG) (93.36 KB - PDF)

View

español (ES) (81.97 KB - PDF)

View

čeština (CS) (93.99 KB - PDF)

View

dansk (DA) (83.34 KB - PDF)

View

Deutsch (DE) (82.76 KB - PDF)

View

eesti keel (ET) (82.18 KB - PDF)

View

ελληνικά (EL) (93.76 KB - PDF)

View

français (FR) (82.44 KB - PDF)

View

hrvatski (HR) (92.27 KB - PDF)

View

íslenska (IS) (83.29 KB - PDF)

View

Gaeilge (GA) (83.57 KB - PDF)

View

italiano (IT) (82.29 KB - PDF)

View

latviešu valoda (LV) (94.29 KB - PDF)

View

lietuvių kalba (LT) (94.03 KB - PDF)

View

magyar (HU) (94.15 KB - PDF)

View

Malti (MT) (95.95 KB - PDF)

View

Nederlands (NL) (82.05 KB - PDF)

View

norsk (NO) (82 KB - PDF)

View

polski (PL) (95.62 KB - PDF)

View

português (PT) (83.01 KB - PDF)

View

română (RO) (94.17 KB - PDF)

View

slovenčina (SK) (94.08 KB - PDF)

View

slovenščina (SL) (82.27 KB - PDF)

View

Suomi (FI) (81.54 KB - PDF)

View

svenska (SV) (82.05 KB - PDF)

View

Product details

Name of medicine
Nobilis Influenza H5N2
Active substance
inactivated whole avian influenza virus antigen of H5N2 subtype (strain A/duck/Potsdam/1402/86)
International non-proprietary name (INN) or common name
adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5

Authorisation details

EMA product number
EMEA/V/C/000118

Accelerated assessment

This medicine had an accelerated assessment. This means that it is a medicine of major interest for public health, so its timeframe for review was 150 evaluation days rather than 210. For more information, see Accelerated assessment.

Assessment history

български (BG) (93.36 KB - PDF)

View

español (ES) (81.97 KB - PDF)

View

čeština (CS) (93.99 KB - PDF)

View

dansk (DA) (83.34 KB - PDF)

View

Deutsch (DE) (82.76 KB - PDF)

View

eesti keel (ET) (82.18 KB - PDF)

View

ελληνικά (EL) (93.76 KB - PDF)

View

français (FR) (82.44 KB - PDF)

View

hrvatski (HR) (92.27 KB - PDF)

View

íslenska (IS) (83.29 KB - PDF)

View

Gaeilge (GA) (83.57 KB - PDF)

View

italiano (IT) (82.29 KB - PDF)

View

latviešu valoda (LV) (94.29 KB - PDF)

View

lietuvių kalba (LT) (94.03 KB - PDF)

View

magyar (HU) (94.15 KB - PDF)

View

Malti (MT) (95.95 KB - PDF)

View

Nederlands (NL) (82.05 KB - PDF)

View

norsk (NO) (82 KB - PDF)

View

polski (PL) (95.62 KB - PDF)

View

português (PT) (83.01 KB - PDF)

View

română (RO) (94.17 KB - PDF)

View

slovenčina (SK) (94.08 KB - PDF)

View

slovenščina (SL) (82.27 KB - PDF)

View

Suomi (FI) (81.54 KB - PDF)

View

svenska (SV) (82.05 KB - PDF)

View

български (BG) (91.78 KB - PDF)

View

español (ES) (81.51 KB - PDF)

View

čeština (CS) (92.48 KB - PDF)

View

dansk (DA) (82.05 KB - PDF)

View

Deutsch (DE) (81.72 KB - PDF)

View

eesti keel (ET) (81.22 KB - PDF)

View

ελληνικά (EL) (91.79 KB - PDF)

View

français (FR) (81.63 KB - PDF)

View

hrvatski (HR) (91.56 KB - PDF)

View

íslenska (IS) (81.52 KB - PDF)

View

Gaeilge (GA) (81.36 KB - PDF)

View

italiano (IT) (81.76 KB - PDF)

View

latviešu valoda (LV) (92.14 KB - PDF)

View

lietuvių kalba (LT) (92.19 KB - PDF)

View

magyar (HU) (92.76 KB - PDF)

View

Malti (MT) (93.86 KB - PDF)

View

Nederlands (NL) (81.15 KB - PDF)

View

norsk (NO) (81.52 KB - PDF)

View

polski (PL) (93.22 KB - PDF)

View

português (PT) (82.53 KB - PDF)

View

română (RO) (91.73 KB - PDF)

View

slovenčina (SK) (81.75 KB - PDF)

View

slovenščina (SL) (81.76 KB - PDF)

View

Suomi (FI) (81.11 KB - PDF)

View

svenska (SV) (81.47 KB - PDF)

View
This page was last updated on

Share this page